{"id":"https://openalex.org/W2384566906","doi":null,"title":"Arsenic trioxide vs all-trans retinoic acid to treat acute promyelocytic leukemia: a systematic comparative review","display_name":"Arsenic trioxide vs all-trans retinoic acid to treat acute promyelocytic leukemia: a systematic comparative review","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2384566906","mag":"2384566906"},"language":"en","primary_location":{"id":"mag:2384566906","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=DSDX200921022","pdf_url":null,"source":{"id":"https://openalex.org/S4306500200","display_name":"Di-san junyi daxue xuebao","issn_l":"1000-5404","issn":["1000-5404"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Di-san junyi daxue xuebao","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2384566906"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102024606","display_name":"Yun Fei Xia","orcid":"https://orcid.org/0000-0001-5824-7899","observed_orcids":["https://orcid.org/0000-0001-5824-7899"]},"institutions":[{"id":"https://openalex.org/I17747738","display_name":"Beijing University of Chinese Medicine","ror":"https://ror.org/05damtm70","country_code":"CN","type":"education","lineage":["https://openalex.org/I17747738"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yun Xia","raw_affiliation_strings":["2Center for Evidence-Based Medicine,Beijing University of Chinese Medicine,Beijing 100029, China)"],"raw_orcid":"https://orcid.org/0000-0001-5824-7899","affiliations":[{"raw_affiliation_string":"2Center for Evidence-Based Medicine,Beijing University of Chinese Medicine,Beijing 100029, China)","institution_ids":["https://openalex.org/I17747738"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102024606"],"corresponding_institution_ids":["https://openalex.org/I17747738"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/arsenic-trioxide","display_name":"arsenic trioxide","score":0.9869999885559082},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":1.0},{"id":"https://openalex.org/keywords/acute-promyelocytic-leukemia","display_name":"acute promyelocytic leukemia","score":1.0},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8109999895095825},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9079999923706055},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.8679999709129333},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.765999972820282},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.8529999852180481},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5609999895095825},{"id":"https://openalex.org/keywords/treatment-efficacy-comparison","display_name":"treatment efficacy comparison","score":0.6150000095367432},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.33899998664855957},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.35499998927116394},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/remission-induction","display_name":"remission induction","score":0.41999998688697815},{"id":"https://openalex.org/keywords/maintenance-therapy-duration","display_name":"maintenance therapy duration","score":0.414000004529953},{"id":"https://openalex.org/keywords/pml-rara-fusion","display_name":"PML-RARA fusion","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C2780386689","wikidata":"https://www.wikidata.org/wiki/Q7739","display_name":"Arsenic trioxide","level":3,"score":0.8338422775268555},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8087435960769653},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.7663666009902954},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6932213306427002},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.6181584596633911},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6035507917404175},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5652785897254944},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.4410143792629242},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4322342276573181},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4245813488960266},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42329227924346924},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40979063510894775},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.2477918565273285},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19576939940452576},{"id":"https://openalex.org/C502230775","wikidata":"https://www.wikidata.org/wiki/Q871","display_name":"Arsenic","level":2,"score":0.053187400102615356},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2384566906","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=DSDX200921022","pdf_url":null,"source":{"id":"https://openalex.org/S4306500200","display_name":"Di-san junyi daxue xuebao","issn_l":"1000-5404","issn":["1000-5404"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Di-san junyi daxue xuebao","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2392501048","https://openalex.org/W2385809010","https://openalex.org/W2380874522","https://openalex.org/W1982894264","https://openalex.org/W2348577342","https://openalex.org/W2382466782","https://openalex.org/W2379625826","https://openalex.org/W1949526623","https://openalex.org/W2353300351","https://openalex.org/W2065756782"],"abstract_inverted_index":{"Objective":[0],"To":[1],"compare":[2],"the":[3,19,31,74,98,106,110,128,158,183,195,310],"efficacy":[4],"and":[5,64,87,146,155,224,278,303],"safety":[6],"of":[7,21,33,78,81,90,112,130,197,259,312,320],"arsenic":[8],"trioxide":[9],"(":[10,16,25,36,40,45,50,55,60,66,83,93,163,174,178,229,235,239,242,246,265],"ATO)":[11],"with":[12,125,157,200],"all-trans":[13],"retinoic":[14],"acid":[15],"ATRA)":[17],"for":[18,100,127,215,257],"treatment":[20,129],"acute":[22],"promyelocytic":[23],"leukemia":[24],"APL)":[26],".":[27,70,167,181],"Methods":[28],"We":[29,71,103,117,132],"searched":[30,73,105],"database":[32],"Cochrane":[34,159],"Library":[35],"Issue":[37],"1,2009)":[38],",CENTRAL":[39],"1970":[41],"to":[42,47,52,57,62,68,85,95,142,220,286,299,318,325],"2009)":[43,53],",Medline":[44],"1978":[46,56],"2008)":[48,58,63,69,86,96],",EMBASE":[49],"1950":[51],",CBM":[54],",CNKI":[59],"1994":[61,67],"CMAC":[65],"also":[72],"Meta":[75,209],"register,Conference":[76],"Proceedings":[77],"American":[79,88],"Society":[80,89],"Hematology":[82],"1946":[84],"Clinical":[91],"Oncology":[92],"2004":[94],"on":[97,194],"internet":[99],"grey":[101],"literature.":[102],"had":[104],"related":[107],"journals":[108],"in":[109,203,288],"library":[111],"Third":[113],"Military":[114],"Medical":[115],"University,too.":[116],"included":[118,177,321],"randomized":[119,171],"controlled":[120,172],"trials":[121,173],"which":[122],"compared":[123],"ATO":[124,198,276,282],"ATRA":[126,201,279,287],"APL.":[131],"adopt":[133],"complete":[134,143,216,221,295,300],"remission":[135],"rate,overall":[136],"survival":[137,140,297],"rate,":[138],"disease-free":[139,218],"rate,time":[141,298],"remission,relapse":[144,222,301],"rate,mortality":[145],"adverse":[147],"reactions":[148],"as":[149,188],"result":[150],"indicators.":[151],"Data":[152],"were":[153,176,185],"entered":[154],"analyzed":[156],"review":[160],"manager":[161],"software":[162],"Revman":[164],"5.":[165],"0)":[166],"Results":[168],"Four":[169],"eligible":[170],"RCTs)":[175],"n":[179],"=243)":[180],"All":[182,249],"RCTs":[184],"methodologically":[186],"graded":[187],"B.":[189],"They":[190],"all":[191],"are":[192],"focusing":[193],"comparison":[196],"monotherapy":[199,202],"treating":[204,289],"newly":[205,290],"diagnosed":[206,291],"APL":[207,292],"patients.":[208],"analysis":[210],"showed":[211,271],"that":[212],"effect":[213],"index":[214,256],"remission,2-year":[217],"survival,time":[219],"rate":[223,302],"mortality":[225],"was":[226,262],"0.":[227,230],"96":[228],"50,1.":[231],"86)":[232],",2.":[233],"76":[234],"0.71,10.66)":[236],",-1.30":[237],"d":[238],"-1.83,-0.78)":[240],",0.86":[241],"0.45,1.63)":[243],",and":[244],"1.15":[245],"0.45,2.95)":[247],",respectively.":[248],"indicated":[250],"no":[251],"statistically":[252,272],"significant":[253,273],"difference.":[254],"Effect":[255],"incidence":[258,311],"liver":[260,313],"dysfunction":[261,314],"3.":[263],"03":[264],"1.":[266],"25,":[267],"7.":[268],"37)":[269],",which":[270],"difference":[274],"between":[275],"group":[277],"group.":[280],"Conclusion":[281],"is":[283,306],"not":[284],"superior":[285],"patients":[293],"regarding":[294],"remission,diseasefree":[296],"mortality.":[304],"What":[305],"worse,it":[307],"will":[308],"increase":[309],"during":[315],"treatment.":[316],"Due":[317],"limitation":[319],"trials,this":[322],"conclusion":[323],"need":[324],"be":[326],"validated":[327],"by":[328],"further":[329],"studies.":[330]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2384566906","counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
